Increased Risk for Cervical Disease Progression of French Women Infected with the Human Papillomavirus Type 16 E6-350G Variant
暂无分享,去创建一个
S. Franceschi | C. Clavel | P. Birembaut | M. Tommasino | I. Zehbe | A. Arslan | G. Besson | M. Grodzki
[1] H. Bernard,et al. Genome variation of human papillomavirus types: Phylogenetic and medical implications , 2006, International journal of cancer.
[2] G. Chandy,et al. HPV 16 E6 sequence variations in Indian patients with cervical neoplasia. , 2005, Cancer letters.
[3] C. Wheeler,et al. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. , 2005, Journal of the National Cancer Institute.
[4] David R. Scott,et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. , 2005, Journal of the National Cancer Institute.
[5] R. DeSalle,et al. The carcinogenicity of human papillomavirus types reflects viral evolution. , 2005, Virology.
[6] R. DeSalle,et al. Diversifying Selection in Human Papillomavirus Type 16 Lineages Based on Complete Genome Analyses , 2005, Journal of Virology.
[7] Andrew Glass,et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci , 2005 .
[8] J. Baseman,et al. The epidemiology of human papillomavirus infections. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[9] C. Wheeler,et al. Loss of heterozygosity on chromosome 6 in HPV‐16 positive cervical carcinomas carrying the DRB1*1501‐DQB1*0602 haplotype , 2004, Genes, chromosomes & cancer.
[10] E. Androphy,et al. Human Papillomavirus Type 16 E6 Amino Acid 83 Variants Enhance E6-Mediated MAPK Signaling and Differentially Regulate Tumorigenesis by Notch Signaling and Oncogenic Ras , 2004, Journal of Virology.
[11] M. Hagensee,et al. Distribution of human papillomavirus type 16 variants in human immunodeficiency virus type 1-positive and -negative women. , 2004, The Journal of general virology.
[12] A. García-Carrancá,et al. Molecular variants of HPV type 16 E6 among Mexican women with LSIL and invasive cancer. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[13] N. Park,et al. Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women , 2004, International Journal of Gynecologic Cancer.
[14] S. Franceschi,et al. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis , 2003, British Journal of Cancer.
[15] M. Tommasino,et al. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. , 2003, Human immunology.
[16] A. Teyssié,et al. Human papillomavirus type‐16 variants in Quechua aboriginals from Argentina , 2003, Journal of medical virology.
[17] K. Vaeteewoottacharn,et al. Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas. , 2003, Anticancer research.
[18] F. X. Bosch,et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.
[19] B. Pollock,et al. Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer. , 2002, Gynecologic oncology.
[20] P. Chan,et al. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. , 2002, The Journal of infectious diseases.
[21] H. Hausen. Papillomaviruses and cancer: from basic studies to clinical application , 2002, Nature Reviews Cancer.
[22] J. Palefsky,et al. Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. , 2002, The Journal of infectious diseases.
[23] N. Kiviat,et al. Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[24] G. Voglino,et al. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes , 2001, International journal of cancer.
[25] L. Banks,et al. The Human Papillomavirus E6 protein and its contribution to malignant progression , 2001, Oncogene.
[26] J. Salmerón,et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. , 2001, Journal of the National Cancer Institute.
[27] C. Clavel,et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women , 2001, British Journal of Cancer.
[28] T. Rohan,et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. , 2000, The Journal of general virology.
[29] G. Voglino,et al. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms , 1998, The Lancet.
[30] E. Wilander,et al. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. , 1998, Cancer research.
[31] K. Holmes,et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. , 1997, Journal of the National Cancer Institute.
[32] C. Wheeler,et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective , 1997, Journal of virology.
[33] H. Stöppler,et al. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation , 1996, Journal of virology.
[34] E. Franco,et al. Persistent human papillomavirus infection and cervical neoplasia. , 2002, The Lancet. Oncology.
[35] H. Gaylord,et al. AMERICAN ASSOCIATION FOR CANCER RESEARCH. , 1913, California state journal of medicine.